无化疗治疗不断升级—BTKi联合CD20单抗在初治MCL老年患者中的协同效应：能否突破“1+1>2”？
点击获取讲者原版演讲幻灯，了解更多内容
This is not an official program of the American Society of Hematology (ASH) and is not endorsed by ASH. The organizers are not associated with ASH or the ASH Annual Meeting
